comparemela.com

Latest Breaking News On - Bio media - Page 4 : comparemela.com

Passage Bio Announces Appointment of William Chou, M D as

Passage Bio Announces Appointment of William Chou, M D as Chief Executive Officer

PHILADELPHIA, Oct. 10, 2022 Passage Bio, Inc. , a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, today announced. | October 10, 2022

NANOBIOTIX and LianBio Announce First Patient Enrolled in Asia in Phase 3 NANORAY-312 Trial Evaluati

Regional activation for Nanobiotix pivotal Phase 3 trial in head and neck cancer proceeds as planned with first patient enrolled in Asia by partner LianBioThe collaboration continues to build momentum behind LianBio’s leadership in Asia while Nanobiotix remains focused on enrollment globallyPARIS & CAMBRIDGE, Mass..

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.